SUBSCRIBE
SUBSCRIBE
Biotech Beach

Clearant, Inc. Announces Its Attendance at FDA Allograft Conference

October 12, 2007 | 
1 min read
LOS ANGELES, CA--(Marketwire - October 12, 2007) - Clearant, Inc. (OTCBB: CLRA) is attending the FDA sponsored workshop on the Processing of Orthopedic, Cardiovascular, and Skin Allografts in Bethesda, Maryland on October 11th and 12th, 2007.
Events
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Medical characters fighting the epidemic flat vector concept operation hand drawn illustration
Obesity
Analysts Home In on Safety as Novo, Lilly, Amgen Highlight Weight Loss Data at ADA
June 27, 2025
 · 
5 min read
 · 
Heather McKenzie
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
June 25, 2025
 · 
1 min read
 · 
BioSpace Insights
Pictured: (From L) Joe Ross, Camille Bedrosian, Emil Kakkis and Heather McKenzie
Rare diseases
FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent
June 24, 2025
 · 
3 min read
 · 
Heather McKenzie
From left to right: Jeff Quillen, Foley Hoag; Jim Cirenza, DNB Bank; Andrew Meadow, Health Innovation Capital; Greg Benning, Back Bay Life Science Advisors; Jonathan Gertler, Back Bay Life Science Advisors
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
June 16, 2025
 · 
2 min read
 · 
Jef Akst